A fund trimmed its position in Johnson & Johnson (JNJ) stock and disclosed the transaction via financial filings with the SEC.
3 reports, 1 independent
Updated Tue 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A fund trimmed its position in Johnson & Johnson (JNJ) stock and disclosed the transaction via financial filings with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Trustee reduced JNJ shares, Amundi boosted position, and HSBC released research reports.1 source
Fund reduced JNJ holdings and filed with the SEC.1 source
Keep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
SEC
Slovak company
Related events
- Director Gerald Johnson purchased Eaton company stock, with the transaction disclosed via an SEC filing.
- Williams Companies filed a disclosure with the SEC on June 6, 2026.
- Norges Bank announced investment activity regarding McDonald's Corporation, including acquiring a new position in MCD shares and trimming its existing stake by 19.3%.
- Insider transaction disclosed in legal filing with SEC, concurrent with MarketBeat providing consensus rating data for JBG SMITH Properties.
- Clover Health Investments disclosed executive stock sales via a filing with the SEC on September 14, 2026.